The stigma associated with oxygen use, its complexity of use and an ‘evidence-free zone’ conspire against achieving optimal management of patients with interstitial lung disease (ILD). A small survey of Australian physicians’ perceptions and experience with oxygen therapy found patient preference was an important factor in whether or not to prescribe oxygen. Co-author Dr Yet ...
Already a member?
Enter your email to keep reading.